Everyone talks about the value of Kevetrin and Pru

Everyone talks about the value of Kevetrin and Prurisol as stand alone products for cancer and psoriasis but very little is mentioned regarding their value as a base for combining with other products, such as Pfizer is doing in it's test overseas with it's own inhibitors for what I think is a drug for leukemia, and that feature IMO increases the overall value of each many fold.  That Seeking Alpha article said that the Kevetrin patent opens the doors for it to be combined with thousands of other products.  That is why I feel even $100-$120 / share is still far below what CTIX products are ultimately worth.

Look at Prurisol as a base to attack all other auto immune diseases and how much does that increase it's value?

Even if both fail (God forbid) their clinical trials the fact they could be used for these other combos still makes them pretty valuable IMO.

Would like to hear how others have looked at the value of our products in regards to their ability to be combined with possibly thousands of other products for new compounds.  IMO this feature gives whatever big pharma buys CTIX a next to unlimited amount of possible new compounds and they would see the value in paying out the gazoo to be able to have such a stable of possible new products.